Find a copy in the library
Finding libraries that hold this item...
Details
| Genre/Form: | Handbook manuals (instructional materials) handbooks Handbooks and manuals Guides et manuels Handbooks, manuals, etc Guides, manuels, etc |
|---|---|
| Document Type: | Book |
| All Authors / Contributors: |
Gary S Marshall |
| ISBN: | 0781735696 9780781735698 |
| OCLC Number: | 455027436 |
| Description: | XV, 415 str. : ilustr. ; 20 cm |
| Contents: | CHAPTER I INTRODUCTION/PREFACE CHAPTER II GENERAL CONSIDERATIONS 1. Background and General Rules 2. Healthy People 2010 Objectives 3. Standards and Regulations 4. The Business of Vaccines in Practice 5. Practical Issues 6. Contraindications and Precautions 7. Vaccine Advocacy 8. Recommended Childhood Immunization Schedule 9. Recommended Adult Immunization Schedule 10. Catch-up Schedules 11. Vaccine Shortages CHAPTER III UNIVERSAL VACCINES FOR CHILDREN AND DOLESCENTS 12. Diphtheria-Tetanus-accellular Pertussis (DTaP) (Form A) 13. Haemophilus Influenzae Type B Polysaccharide Conjugate (Hib) (Form A) 14. Hepatitis B (Form A) 15. Inactivated Poliovirus (IPV) (Form A) 16. Measles-Mumps-Rubella (MMR) (Form A) 17. Pneumococcal Polysaccharide Conjugate (PCV) (Form A) 18. Varicella CHAPTER IV NEWER COMBINATION VACCINES 19. DTaP-Hib (Form A) 20. Hepatitis B-Hib (Form A) 21. Hepatitis B-Hepatitis A (Form A) CHAPTER V. VACCINES FOR ADULTS AND SELECTED CHILDREN 22. Influenza (Form A) 23. Pneumococcal Polysaccharide (Form A) 24. Diphtheria-Tetanus (dT) (Form A) CHAPTER VI. VACCINES FOR SPECIALIZED USE 25. Adenovirus (Form A) 26. Bacille Calmette-Guerin (BCG) (Form A) 27. Cholera (Form A) 28. Hepatitis A (Form A) 29. Japanese Encephalitis Virus (Form A) 30. Lyme (Form A) 31. Meningococcal Polysaccharide (Form A) 32. Rabies (Form A) 33. Typhoid (Form A) 34. Yellow Fever (Form A) CHAPTER VII. VACCINES AND BIOTERRORISM 35. General Considerations 36. Classification of Agents for Bioterrorism 37. General Strategies for Responding to Terrorism with Vaccination 38. Specific Vaccines CHAPTER VIII. VACCINES IN DEVELOPMENT FOR GENERAL USE 39. Institute of Medicine Report (Form B) 40. Combinations (Form B) 41. Cytomegalovirus (Form B) 42. Epstein-Barr Virus (Form B) 43. Herpes Simplex Virus (Form B) 44. Human Immunodeficiency Virus (Form B) 45. Human Papilloma Virus (Form B) 46. Live Cold-Adapted Influenza (Form B) 47. Meningococcal Polysaccharide Conjugate (Form B) 48. Increased Valency Pneumococcal Polysaccharide Conjugates (Form B) 49. Parainfluenza Virus (Form B) 50. Respiratory Syncytial Virus (Form B) 51. Rotavirus (Form B) CHAPTER IX.PASSIVE IMMUNIZATION 52. Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) (Form A) 53. Hepatitis B Immune Globulin (HBIG) (Form A) 54. Immune Globulin (IG) (Form A) 55. Palivizumab (humanized RSV monoclonal antibody) (Form A) 56. Rabies Immune Globulin (RIG) (Form A) 57. Respiratory Syncytial Virus Immune Globulin Intravenous (RSV-IGIV) (Form A) 58. Tetanus Immune Globulin (TIG) (Form A) 59. Varicella Zoster Immune Globulin (VZIG) (Form A) 60. Antitoxins (Form A) CHAPTER X. VACCINATION IN SPECIAL CIRCUMSTANCES 61. Congenital Immunodeficiencies 62. Human Immunodeficiency Virus Infection 63. Immunosuppressive Chemotherapy 64. Bone Marrow Transplantation 65. Steroids 66. Functional and Anatomic Asplenia 67. Chronic Diseases 68. Patients with Passively Acquired Antibodies 69. Pregnancy and Breastfeeding 70. Preterm Infants 71. Blee |
| Responsibility: | Gary S. Marshall. |
Reviews
